NIH Funding · FY2024
Total Funding
$2.4M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#4,036
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $2.4M across 2 grants · National rank #4036.
Top grants by award amount
David Sultzer's NIH grant portfolio, ranked by award amount.
- 5R01AG074983-03R01Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.$2.2Maward amount
- 5P30AG066519-05P30The Alzheimer's Disease Research Center at the University of California, Irvine$108Kaward amount
Affiliations
Institutions that have administered grants for David Sultzer.
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardInstitute for Molecular Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4036
- 2024Entered Top 25% NationallyRanked #4036
- 2024Multi-Institutional ResearchAwards at 2 institutions
Related investigators
Other NIH-funded PIs frequently associated with David Sultzer.
Explore further
Find collaborators for David Sultzer
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Institute for Molecular Medicine
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →